Clinical Trial Update: A Randomized, Controlled Trial of Ganaxolone in Patients With Infantile Spasms [Phase 2]

View source ↗

Summary

Phase 2 randomized trial of ganaxolone in infants with infantile spasms has been completed; results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infantile Spasms

Drugs mentioned

• ganaxolone (ganaxolone)

Snippet

Sponsor: Marinus Pharmaceuticals | Conditions: Infantile Spasms | Phase 2 | Status: COMPLETED | Results posted: 2023-06-02